Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure

European Journal of Clinical Pharmacology

Volumn 50, Issue 4, 1996, Pages 265-268

  Pinto, Y M ^a   Van Veldhuisen, D J ^a   Tjon Ka Jie, R T ^b   Rooks, G ^a   Netzer, T ^c   Lie, K I ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Scheper Ziekenhuis   (Netherlands)

^c Clinical Research   (Germany)

Author keywords

Angiotensin converting enzyme; Blood pressure; Circulating ACE; Heart failure; ACE inhibitor; Imidapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMIDAZOLES; IMIDAZOLIDINES; MALE; MIDDLE AGED;

EID: 0029950254     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050105     Document Type: Article

References (18)

1. Braunwald E (1991) ACE inhibitors A cornerstone in the treatment of heart failure. N. Engl J Med 325:351-353
2. Deedwania PC (1990) Angiotensin-converting enzyme inhibitors in congestive heart failure. Arch Int Med 150:1798-1805
3. Lang RM, DiBianco R, Broderick GT, Gottlieb SS, Kostis J, Lyle PA, Makris L, Rajfer SI, Rucinska EJ (1994) First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double blind, randomized, multicenter study. Am Heart J 128:551-556
4. Motwani JG, Fenwick MK, Morton JJ, Struthers AD (1994) Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 73: 1191-1196
5. Pinto YM, de Smet BJGL, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H (1993) Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res 27: 1933-1938
6. Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H (1994) Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest 94:301-310
7. VandenBurg MJ, MacKay EM, Dews I, Pullan T, Brugier S (1994) Dose finding studies with imidapril a new ACE inhibitor. Br J Clin Pharmacol 37:265-272
8. Packer M, Medina N, Yushak M (1983) Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol 3:1035-1043
9. Kwarts E, Beukeveld GJJ, Gazendam J (1982) Evaluation of a simple colorimetric assay for serum angiotensin converting enzyme: comparisation with a new ion-pair liquid chromatography assisted assay. Ann Clin Biochem 227-232
10. Van Veldhuisen DJ, Van Gilst WH, De Smet BJGL, De Graeff PA, Scholtens E, Buikema H, Girbes ARJ, Wesseling H, Lie KI (1994) Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. Cardiovasc Drugs Ther 8:245-250
11. MacFadyen RJ, Lees KR, Reid JL (1991) Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo-controlled study. Br Heart J 66:206-211
12. Reid JL, MacFadyen RJ, Squire IB, Lees KR (1993) Angiotensin-converting enzyme inhibitors in heart failure-lood pressure changes after the 1st dose. Am Heart J 126:794-797
13. Squire IB, MacFadyen RJ, Lees KR, Hillis WS, Reid JL (1994) Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. Br J Clin Pharmacol 38: 117-123
14. Unger T, Moursi M, Ganten D, Hermann K, Lang RE (1986) Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (HOE498). J Cardiovasc Pharmacol 8:276-285
15. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ (1991) Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69:475-482
16. Van Gilst WH, Van Veldhuisen DJ, Hegeman H, Buikema H, Scholtens E, De Graeff PA, Lie KI (1994) Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. J Cardiovasc Pharmacol 24:171-174
17. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ (1990) Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure (review). Am J Cardiol 66:22D-32D
18. Paul M, Pinto Y, Schunkert H, Ganten D, Böhm M (1994) Activation of the renin-angiotensin system in heart failure and hypertrophy: studies in human hearts and transgenic rats. Eur Heart J 15 [Suppl D]: 63-67